Evaluation of the health-related quality of life of patients with type 2 diabetes in relation to macrovascular and microvascular complications
Purpose The complications of type 2 diabetes (T2DM) have a negative impact on health-related quality of life (HRQoL) and could lead to increased healthcare costs. However, there is a lack of evidence regarding how and to what extent T2DM complications, particularly macrovascular and microvascular co...
Gespeichert in:
Veröffentlicht in: | Acta diabetologica 2023-12, Vol.60 (12), p.1735-1747 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
The complications of type 2 diabetes (T2DM) have a negative impact on health-related quality of life (HRQoL) and could lead to increased healthcare costs. However, there is a lack of evidence regarding how and to what extent T2DM complications, particularly macrovascular and microvascular complications, affect the patients’ HRQoL. This study aimed to evaluate the HRQoL in relation to diabetes complications and identify associated factors among patients with T2DM.
Methods
A cross-sectional study was conducted over six months on T2DM patients at a National University Hospital, Malaysia. Since Malaysia is a multiethnic country with majority Malay-speaking and English widely used, the Malay and English versions of the revised version Diabetes Quality of life (DQoL) questionnaire was used to measure HRQoL. Multiple Linear Regression was applied to estimate association of individual DQoL domains with T2DM-related complications, sociodemographic and clinical characteristics.
Results
A total of 513 patients were recruited in the study. Sociodemographic (age, gender, ethnicity, employment, education) and body mass index affected
satisfaction, impact
and
worry
domains while complications affected the
impact
domain. Poorer HRQoL were demonstrated for severe stages heart failure (
p
= 0.001), nephropathy (
p
= 0.029), retinopathy (
p
|
---|---|
ISSN: | 1432-5233 0940-5429 1432-5233 |
DOI: | 10.1007/s00592-023-02164-2 |